Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial (Q36627196)
Jump to navigation
Jump to search
scientific article published on 8 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial |
scientific article published on 8 December 2015 |
Statements
1 reference
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial (English)
1 reference
C Chouaid
1 reference
M Schuler
1 reference
J C-H Yang
1 reference
K Park
1 reference
J-H Kim
1 reference
J Bennouna
1 reference
Y-M Chen
1 reference
F De Marinis
1 reference
J-F Feng
1 reference
D-W Kim
1 reference
X Liu
1 reference
S Lu
1 reference
J Strausz
1 reference
Y Vinnyk
1 reference
R Wiewrodt
1 reference
C Zhou
1 reference
B Wang
1 reference
V K Chand
1 reference
D Planchard
1 reference
LUX-Lung 5 Investigators
1 reference
8 December 2015
1 reference
1 reference
417-423
1 reference
Identifiers
1 reference
1 reference
1 reference